1Rebay I, Fehon RG, Axmvsuis- Tsakomm S. Specific truncatloes of Drosophila Notch define dominant activated and dominant negative forms of the reeeptor[J]. Cell, 1993 ,74:319.
2Laurie A Milner,Anna Bips.Notch as a mediator cell fate determination in hematopoiesis: evidence and speculation[ J]. Blood, 1999,93:2431.
3Milner LA, Bigas A, Kopan R, et al. Inhibition of granulocytic differentiation by mNotehl[J] .Proe Natl Aeatd Sci USA, 1996,93:13014.
4Jundt F,Anagnogtopoulos I,Forater R,et al.Activated Notchl signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma[J]. Blood,2002,99:3398.
5Allman D,Karnell FG,Punt JA,et al. Separation d Notchl promoted lineage commitment andexpansion/trandormation in developing T cells[ J]. J Exp Meal,2001,194(1) :99.
6Oomen SP,Ward AC, Hofland LJ,et a]. Somatostatin modulates G - CSF -induced but not interleukin - 3 - induced proliferative responses in myeloid 32D cells via activation of somatostatin receptor subtype 2 [J ].Hematol,2001,2(5) :322.
7Yoneya T,Tagara T, Nasao K,el al. Molecular cloning d delta - 4,a new mouse and human notch ligand[ J] .J Biochem(Tokyo),2001, 129:27.
8Lewis J. A short cut to the nucleus [J]. Nature, 1998,393:304.
9Rebay I, Fehon RG, Artavanis-Tsakonas S. Specific truncations of Drosophila Notch define dominant acti-vated and dominant negative forms of the receptor[J].Cell , 1993, 74:319.
10Yoneya T, Tahara T, Nagao K, et al. Molecular cloning of deha-4, a new mouse and human notch ligand[J]. J Biochem(Tokyo), 2001, 129 (1) :27.
